Skip to main content
Clinical Trials/NCT04959604
NCT04959604RecruitingNot Applicable

Lymph Node Mapping Via the Flourescent Dye ICG in Colon Cancer Through Preoperative Application

Universitätsklinikum Hamburg-Eppendorf1 site in 1 country30 target enrollmentStarted: May 31, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
30
Locations
1
Primary Endpoint
Video-analysis of ICG-positive lymph nodes in vivo after endoscopic marking of the tumour

Study Overview

Brief Summary

The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative.

The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.

The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative.

The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.

Detailed Description

Participants with a diagnosed (andeno)carcinoma of the ascending, transverse, descending and sigmoid colon will be included. Preoperatively the participants will receive an indocyanine green(ICG) injection at four points around the tumour endoscopically. The ICG marking will take place one to five days prior to surgery. In the draining lymph nodes of the specific region the ICG will accumulate and thus visible via fluorescence-camera during the surgery.

Intraoperatively, the precise locations of all fluorescent nodes will be documented photographically. A standard resection and lymph node dissection will be conducted, potential fluorescent nodes outside the standard resection lines will additionally be resected. The fresh specimen will then be measured, the fluorescent nodes marked and after the pathologic examination the nodes will be correlated to location, fluorescent yes/no and nodal positive/negative.

The aim ist not the visualization of the Sentinel node or the directly draining lymphatic vessel but all the nodes draining the peritumorous region at the point of surgery.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •histologically diagnosed carcinoma of the ascending, transverse, descending or sigmoid colon.

Exclusion Criteria

  • •not wanting to participate
  • •other carcinoma then adenocarcinoma
  • •endoscopic marking not possible

Arms & Interventions

ICG-marked Colon Carcinoma

Experimental

The participants will receive an endoscopic marking via ICG preoperatively

Intervention: ICG-marking endoscopically (Procedure)

Outcomes

Primary Outcomes

Video-analysis of ICG-positive lymph nodes in vivo after endoscopic marking of the tumour

Time Frame: video-analysis within one week after surgery

Counting ICG-positive sites video-analysis

Intraoperative ICG-positive lymph nodes in vivo after endoscopic marking of the tumour

Time Frame: intraoperative assessment

Counting ICG-positive sites intraoperatively

Correlation of nodal-positive lymph nodes inside/outside the standard resection area

Time Frame: within one week after surgery

ICG-positive sites outside standard resection area will be "cherry picked", sent to pathological examination separatively.

Number of ICG-positive lymph nodes after endoscopic marking of the tumour

Time Frame: within one week after surgery

Picking ICG-positive lymph nodes ex vivo in unfixed specimen, sending ICG positive nodes separately to pathological examination

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials